|
WDFY3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.259700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.936200E-01 |
| Normal-vs-Stage2 |
2.629600E-01 |
| Normal-vs-Stage3 |
2.35679999999183E-05 |
| Normal-vs-Stage4 |
2.82779999971616E-07 |
| Stage1-vs-Stage2 |
4.957600E-01 |
| Stage1-vs-Stage3 |
9.59329999999925E-05 |
| Stage1-vs-Stage4 |
2.9586000005466E-07 |
| Stage2-vs-Stage3 |
1.165370E-01 |
| Stage2-vs-Stage4 |
2.578200E-02 |
| Stage3-vs-Stage4 |
2.756400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.041400E-03 |
| Normal-vs-AfricanAmerican |
8.957000E-03 |
| Normal-vs-Asian |
6.442200E-01 |
| Caucasian-vs-AfricanAmerican |
5.185400E-01 |
| Caucasian-vs-Asian |
6.626000E-01 |
| AfricanAmerican-vs-Asian |
4.590000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.46909999999101E-05 |
| Normal-vs-Female |
8.554600E-01 |
| Male-vs-Female |
2.32109999998009E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.589500E-04 |
| Normal-vs-Age(41-60Yrs) |
6.190300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.698380E-03 |
| Normal-vs-Age(81-100Yrs) |
3.608000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.035700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.241750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.754830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.493990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.746600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.568600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.093600E-02 |
| Normal-vs-Grade 2 |
6.330600E-01 |
| Normal-vs-Grade 3 |
4.641400E-04 |
| Normal-vs-Grade 4 |
1.15280007761953E-11 |
| Grade 1-vs-Grade 2 |
5.147600E-02 |
| Grade 1-vs-Grade 3 |
3.000300E-04 |
| Grade 1-vs-Grade 4 |
6.36620001159827E-09 |
| Grade 2-vs-Grade 3 |
6.595500E-04 |
| Grade 2-vs-Grade 4 |
3.31601412995042E-12 |
| Grade 3-vs-Grade 4 |
2.36860000002448E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.058850E-01 |
| Normal-vs-ccB subtype |
3.12910000022093E-07 |
| ccA subtype-vs-ccB subtype |
1.06581410364015E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.223900E-02 |
| Normal-vs-N1 |
1.558520E-03 |
| N0-vs-N1 |
1.028360E-01 |
|
|
